ORUKA THERAPEUTICS INC (ORKA) Stock Analyst Earnings Estimates
NASDAQ:ORKA - Nasdaq - US6876041087 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||||||
| EBITDA YoY % growth | -9.68M | -11.44M -18.18% | -16.59M -45.02% | -18.68M -12.60% | -8.1M 56.64% | -5.79M 28.52% | -9.76M -68.57% | -19.319M -97.94% | -10.576M 45.26% | -7.281M 31.16% | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.69M | -11.46M -18.27% | -16.61M -44.94% | -18.71M -12.64% | -8.12M 56.60% | -5.81M 28.45% | -9.77M -68.16% | -19.335M -97.90% | -10.596M 45.20% | -7.296M 31.14% | N/A -913.35% | N/A -59.06% | N/A -17.80% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -120.96 71.85% | -54.36 55.06% | N/A | N/A | N/A | N/A | N/A | N/A 14.37% | N/A 27.23% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.70 | -0.45 | -0.49 | -0.50 65.67% | -0.54 22.59% | -0.54 -21.28% | -0.57 -16.83% | -0.61 -21.39% | -0.65 -20.03% | -0.59 -8.77% | -0.61 -7.35% | -0.63 -4.27% |
| Revenue Q2Q % growth | N/A | N/A | N/A | |||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.013M -1,536.06% | -25.679M -934.59% | -27.744M -788.66% | -29.019M -37.29% | -31.544M -21.26% | -40.8M -58.89% | -43.86M -58.09% | -46.92M -61.69% | -49.98M -58.45% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.46 -1,360.00% | -0.41 | -1.05 | -256.21% |
| Q2 2020 Q2Q % growth | -8.76 35.96% | -31.58 | 22.82 | 72.26% |
| Q1 2020 Q2Q % growth | -9.96 55.38% | -24.97 | 15.01 | 60.11% |
| Q4 2019 Q2Q % growth | -9.24 | -12.12 | 2.88 | 23.75% |
| Q3 2019 Q2Q % growth | -9.12 | -15.91 | 6.79 | 42.68% |
| Q2 2019 Q2Q % growth | -13.68 | -22.77 | 9.09 | 39.91% |
| Q1 2019 Q2Q % growth | -22.32 | -24.24 | 1.92 | 7.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |